A year ago, ZenLeaf in Elizabeth was one of 13 dispensaries that officially opened for recreational marijuana sales in New Jersey. Since then, sales have been nonstop, according to general manager Sonny Achrekar. “We’re always get new people in and now that the weather is getting better, we’re going to get all the people flying in because we get all the airport traffic. So it’s just consistent,” he said.
Cannabis Regulatory Commission
New Jersey’s recreational cannabis industry launched one year ago, and Dominic Rivera is nearly $1 million in debt.
The Camden man thought his drive-through dispensary would be open by now, but it took 13 months to get the state to OK his application — approval he received just last week. In the meantime, he is nearly finished with construction, has hired nine employees, and has spent thousands on electricity for a store that can’t have any customers yet.
In the aftermath of the decision by the New Jersey Cannabis Regulatory Commission (CRC) to rescind its previous vote denying the renewal of adult-use licenses to the industry’s largest MSO – an about-face one could see coming a mile away – Curaleaf CEO Matt Darin and Chairman Boris Johnson issued a public proclamation declaring a decisive victory over a vanquished enemy, as if they had just stormed the beach at Normandy. Even in victory, however, their celebratory comments could barely contain the contempt they still have for the CRC.
New Jersey’s adult-use cannabis market is still getting going, but that didn’t stop a handful of licensed retailers grandfathered in from the medical program from recording more than a half billion dollars in cannabis sales for 2022.
With nearly $329 million in adult-use sales since the state's launch last April, and more than $226 million in medical sales, New Jersey’s licensed retail market cashed in $555 million altogether in 2022, according to recently released figures from the state’s Cannabis Regulatory Commission (CRC).
Curaleaf can continue selling recreational cannabis at all of its New Jersey locations after the state’s cannabis regulators reversed a decision they made Thursday that would have sharply limited where the company can sell weed.
In a stunning move, New Jersey regulators on Thursday stripped away the right to sell legal weed to recreational customers from one of the world's largest cannabis companies.
Curaleaf, with nearly 150 dispensaries in the United States, will be required to halt all recreational marijuana sales at its Bellmawr and Edgewater Park dispensaries as of April 21 after the New Jersey Cannabis Regulatory Commission voted to deny a renewal of its annual license, with two "no" votes, two abstentions and just one "yes" vote.
Cannabis regulators on Thursday denied Curaleaf, the biggest player in New Jersey’s nascent cannabis industry, a renewal of the license that allows it to grow and sell recreational marijuana in the Garden State.
The vote represents a surprising blow to the cannabis giant, and comes just about a week before the first anniversary of recreational weed sales in the state. It left observers stunned, and a representative of Curaleaf seeking help from the attorney general and wondering aloud about legal action.
A company based in Wayne, Pennsylvania, is scheduled to appear before the city zoning board on Monday seeking a variance to construct a 57,000-square-foot, two-story cannabis-cultivation facility on Carman Street, north of Admiral Wilson Boulevard.
As Promised Holdings LLC owns the property around 1600 Carman Street, between South 16th and South 17th streets, and proposes to demolish long-vacant buildings to make way for the recreational marijuana growing building.
The Apothecarium Dispensary, with locations in Lodi and Phillipsburg, two of the state's 16 existing medical marijuana dispensaries, has applied to the state to open a third dispensary in Berkeley Heights, in Union County.
Other Central New Jersey dispensary locations in Woodbridge, Eatontown and Union Township began selling marijuana to adults over 21 years old a year ago, according to parent company AYR Wellness.
The medical marijuana dispensaries were approved to convert to recreational sales by the New Jersey Cannabis Regulatory Commission in May of last year.
“The market is developing, and we don’t want to hinder that. The New Jersey canopy is currently only 418,000 square feet—far below the average of other states with legal cannabis,” said Commissioner Maria Del Cid-Kosso. “New Jersey currently has only one cultivation license for every 197,000 residents. The national average is one license for every 31,000 residents. We have a lot of room to grow. We expect that lifting the cap will open the space for more cultivators, ultimately resulting in more favorable pricing and better access for patients and other consumers.”